Skip to main content

Pfizer’s COVID-19 vaccine 95% effective in final results, company to seek approval within days

The companies said they have collected the two months of safety data on about 19,000 study subjects requested by the U.S. Food and Drug Administration.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.